Stock Events

Stock Events

Seres Therapeutics (MCRB) Q3 2025 Earnings

6AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-3.93

-1.37

1.19

3.75

Details

Expected EPS

-2.49

Actual EPS

-2.27

Surprise EPS

0.22

Surprise Percent

+8.84%

Description

Seres Therapeutics (MCRB) has reported earnings of -2.27 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.